| Catherine Wilson, | |
|
104 Ridgely Ave, Annapolis, MD 21401-1439 | |
| (410) 280-9500 | |
| Not Available |
| Full Name | Catherine Wilson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 104 Ridgely Ave, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881185270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R193677 (Maryland) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | R193677 (Maryland) | Primary |
| Entity Name | Annapolis Family Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548601883 PECOS PAC ID: 7416186838 Enrollment ID: O20140206000218 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D).
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Researchers at Washington University School of Medicine in St. Louis and the University of Pennsylvania have found an immune system cell can "remember" a parasite's attack and help the body mount a more effective defense against subsequent invasions by the same parasite.
Dutch researcher Manon Franssen has shown that cells which heal the skin following an injury play an important role in the development of the skin disease psoriasis. In people with psoriasis, the skin peels much faster than normal so that it flakes and becomes inflamed.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Wilson, 1126 Skyway Dr, Annapolis, MD 21409-4905 Ph: () - | Catherine Wilson, 104 Ridgely Ave, Annapolis, MD 21401-1439 Ph: (410) 280-9500 |
News Archive
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate in Type 2 Diabetes (TINSAL-T2D).
Alticor and Metagenics today announced that they have entered into a joint venture agreement. Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance.
Researchers at Washington University School of Medicine in St. Louis and the University of Pennsylvania have found an immune system cell can "remember" a parasite's attack and help the body mount a more effective defense against subsequent invasions by the same parasite.
Dutch researcher Manon Franssen has shown that cells which heal the skin following an injury play an important role in the development of the skin disease psoriasis. In people with psoriasis, the skin peels much faster than normal so that it flakes and becomes inflamed.
› Verified 4 days ago
Brenda Kay Mathews-vitello, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 Defense Hwy, Suite 400, Annapolis, MD 21401 Phone: 410-897-9841 Fax: 410-897-9852 | |
Mrs. Jillian Lynn Preston, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 166 Defense Hwy Ste 101, Annapolis, MD 21401 Phone: 877-461-1564 | |
Alexa Lee St Laurent, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2024 West St Ste 400, Annapolis, MD 21401 Phone: 410-224-7667 Fax: 410-224-7007 | |
Dabney Lipscomb, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Wayson Pavilion, Suite 150, Annapolis, MD 21401 Phone: 443-481-1199 Fax: 443-481-1495 | |
Ms. Stephanie Zwonitzer, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-1750 | |
Mrs. Hollis Stewart Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 678 Genessee St, Annapolis, MD 21401 Phone: 412-508-7896 | |
Lisa Kristine Butler, MSN, CRNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2002 Medical Pkwy Ste 670, Annapolis, MD 21401 Phone: 443-481-1150 |